FMC is a premium stock of StocksGuide. Please log in to activate an alert for FMC.
Register for Free
Please register for free to add FMC to your portfolio.
FMC Stock News
$5.63
7.25%
NYSE, Nov 06, 04:18 pm EST.
Closed.
Why the stock moved
StocksGuide Unlimited – full access to AI analyses
With Unlimited you get the full AI functionality for FMC. 👉 More detailed insights 👉 Exclusive perspectives on opportunities & risks 👉 Clear answers to your questions
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings of ‘BBB- (sf)' to the Series 2026-GT2, Class A Term Notes from FMC GMSR ISSUER TRUST, Freedom Mortgage Corporation's (FMC) master trust issuer of notes backed by a participation certificate evidencing a participation interest in mortgage servicing rights (MSR) on loans underlying Ginnie Mae guaranteed mortgage bac...
Company provides additional detail on financial impact of previously announced commercial actions Third Quarter 2026 Highlights Revenue of $106 million, down $436 million versus Q3 2025, including an approximately $639 million negative impact from previously announced commercial actions Consolidated GAAP net loss of $2.07 billion, a decline of $1.50 billion versus Q3 2025 driven by non-cash adj...
LOS ANGELES--(BUSINESS WIRE)---- $FMC--FMC Investors with $100,000 in Losses Have Opportunity to Join FMC Corporation Fraud Investigation with SBS Law.
Third-quarter revenue 1 is now expected to be $65 million to $125 million, with Adjusted EBITDA 2 expected to be negative $565 million to negative $510 million Revised expectations now include commercial actions which are resulting in approximately $625 million to $675 million in charges impacting revenue 1 and Adjusted EBITDA 2 Commercial actions are expected to accelerate movement of FMC prod...
Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeans PHILADELPHIA, Sept. 28, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced the submission of the regulatory dossier for rimisoxafen to Brazilian regulatory authorities.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.